Reinhart Partners LLC. Has $8.54 Million Position in Avantor, Inc. $AVTR

Reinhart Partners LLC. lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 21.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 687,805 shares of the company’s stock after purchasing an additional 119,476 shares during the period. Reinhart Partners LLC.’s holdings in Avantor were worth $8,539,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. TD Private Client Wealth LLC boosted its stake in Avantor by 9.2% in the third quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock valued at $100,000 after acquiring an additional 670 shares during the last quarter. Truist Financial Corp boosted its position in shares of Avantor by 2.2% in the 2nd quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock worth $597,000 after purchasing an additional 959 shares during the last quarter. SG Americas Securities LLC grew its stake in shares of Avantor by 2.7% during the second quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock worth $499,000 after purchasing an additional 979 shares during the period. Louisiana State Employees Retirement System increased its holdings in Avantor by 0.5% in the second quarter. Louisiana State Employees Retirement System now owns 191,700 shares of the company’s stock valued at $2,580,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Osaic Holdings Inc. increased its holdings in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Price Performance

Shares of AVTR opened at $12.15 on Friday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.96 and a current ratio of 1.49. The stock has a 50 day simple moving average of $11.52 and a 200 day simple moving average of $12.56. Avantor, Inc. has a 52-week low of $10.62 and a 52-week high of $23.32. The firm has a market capitalization of $8.28 billion, a PE ratio of -93.46, a P/E/G ratio of 4.16 and a beta of 0.93.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 29th. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.01). The company had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.65 billion. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The business’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter last year, the business posted $0.26 earnings per share. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. Sell-side analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Gregory L. Summe bought 100,000 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average price of $11.25 per share, for a total transaction of $1,125,000.00. Following the completion of the acquisition, the director owned 300,000 shares of the company’s stock, valued at approximately $3,375,000. The trade was a 50.00% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Sanjeev K. Mehra acquired 350,000 shares of the business’s stock in a transaction dated Friday, December 5th. The stock was bought at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the acquisition, the director owned 350,000 shares in the company, valued at $3,881,500. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 1.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on AVTR. Jefferies Financial Group cut Avantor to an “underperform” rating in a report on Wednesday, December 17th. Evercore ISI set a $12.00 price target on shares of Avantor and gave the company an “in-line” rating in a research report on Monday, January 5th. Barclays reissued an “equal weight” rating and set a $12.00 price objective (down previously from $15.00) on shares of Avantor in a research note on Thursday, October 30th. UBS Group set a $12.00 target price on shares of Avantor in a research note on Thursday, October 30th. Finally, Raymond James Financial lowered shares of Avantor from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 4th. Three analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Avantor currently has an average rating of “Hold” and a consensus price target of $13.60.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.